GlassScriptPhysician profile
Maria D Mandry
NPI 1700392172
$8,192.91
in general payments reported to CMS, 2019-2025
42 companies · $1,978 in 2025
The $1,978 reported for 2025 was more than what 93% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,894 · 2022: $1,400 · 2023: $1,544 · 2024: $1,377 · 2025: $1,978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,898.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,189.90 | 2021-2025 | Mounjaro, Jardiance, Lyumjev |
| Novo Nordisk INC | $939.12 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Sanofi-Aventis U.S. LLC | $680.60 | 2021-2025 | |
| Dexcom, INC. | $576.36 | 2021-2025 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $466.25 | 2021-2025 | |
| Esperion Therapeutics, INC. | $401.91 | 2021-2024 | Nexletol |
| Radius Health, INC. | $381.29 | 2021-2025 | Tymlos |
| Abbvie INC. | $361.46 | 2021-2025 | |
| Amgen INC. | $320.90 | 2021-2025 | Tepezza, Evenity, Prolia |
| Xeris Pharmaceuticals, INC. | $307.57 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Boehringer Ingelheim Pharmaceuticals, INC. | $266.00 | 2021-2025 | Jardiance, Tradjenta, Trijardy Xr |
| Amneal Pharmaceuticals LLC | $204.23 | 2022-2025 | Unithroid |
| Corcept Therapeutics | $204.13 | 2021-2025 | Korlym |
| Clarus Therapeutics INC. | $188.47 | 2021 | |
| Tandem Diabetes Care, INC. | $183.47 | 2021-2024 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Mandry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.